Teletherapy for Anxiety and Depression in Type 1 Diabetes
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
- Age
- 18 – 64
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 94 (estimated)
- Sponsor
- Albert Einstein College of Medicine · Other
This trial is looking for adults with type 1 diabetes who experience anxiety or depression. Participants will undergo teletherapy sessions using a specific therapy method while their glucose levels are monitored.
You may be able to join if
- I have had type 1 diabetes for at least 6 months
- I am between 18 and 64 years old
- I speak English or Spanish
- I have been diagnosed with an anxiety or depressive mood disorder
You may not be able to join if
- I have a disability that affects my ability to participate
- I am currently pregnant
- I have bipolar disorder or psychosis
- I have severe eating disorders or substance abuse issues
- I am at acute risk of suicide or self-harm
- I have recently started medication that affects my blood sugar
- I received cognitive behavioral therapy in the last year
- I have recently started psychotropic medication and I am not stable on it for 6 weeks
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
Loading trial locations…